These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
398 related articles for article (PubMed ID: 25614132)
1. In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia. Wijtenburg SA; Yang S; Fischer BA; Rowland LM Neurosci Biobehav Rev; 2015 Apr; 51():276-95. PubMed ID: 25614132 [TBL] [Abstract][Full Text] [Related]
2. Current Practice and New Developments in the Use of In Vivo Magnetic Resonance Spectroscopy for the Assessment of Key Metabolites Implicated in the Pathophysiology of Schizophrenia. Dwyer GE; Hugdahl K; Specht K; Grüner R Curr Top Med Chem; 2018; 18(21):1908-1924. PubMed ID: 30499397 [TBL] [Abstract][Full Text] [Related]
3. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings. Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853 [TBL] [Abstract][Full Text] [Related]
4. In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia. Puhl MD; Mintzopoulos D; Jensen JE; Gillis TE; Konopaske GT; Kaufman MJ; Coyle JT Neurobiol Dis; 2015 Jan; 73():269-74. PubMed ID: 25461193 [TBL] [Abstract][Full Text] [Related]
5. In vivo measurements of glutamate, GABA, and NAAG in schizophrenia. Rowland LM; Kontson K; West J; Edden RA; Zhu H; Wijtenburg SA; Holcomb HH; Barker PB Schizophr Bull; 2013 Sep; 39(5):1096-104. PubMed ID: 23081992 [TBL] [Abstract][Full Text] [Related]
6. In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy. Kegeles LS; Humaran TJ; Mann JJ Biol Psychiatry; 1998 Sep; 44(6):382-98. PubMed ID: 9777167 [TBL] [Abstract][Full Text] [Related]
7. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769 [TBL] [Abstract][Full Text] [Related]
8. Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism. Duarte JMN; Xin L Neurochem Res; 2019 Jan; 44(1):102-116. PubMed ID: 29616444 [TBL] [Abstract][Full Text] [Related]
9. Glutathione and glutamate in schizophrenia: a 7T MRS study. Kumar J; Liddle EB; Fernandes CC; Palaniyappan L; Hall EL; Robson SE; Simmonite M; Fiesal J; Katshu MZ; Qureshi A; Skelton M; Christodoulou NG; Brookes MJ; Morris PG; Liddle PF Mol Psychiatry; 2020 Apr; 25(4):873-882. PubMed ID: 29934548 [TBL] [Abstract][Full Text] [Related]
10. Precision of metabolite-selective MRS measurements of glutamate, GABA and glutathione: A review of human brain studies. Kanagasabai K; Palaniyappan L; Théberge J NMR Biomed; 2024 Mar; 37(3):e5071. PubMed ID: 38050448 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous quantification of GABA, Glx and GSH in the neonatal human brain using magnetic resonance spectroscopy. Maria YL; Price AN; Puts NAJ; Hughes EJ; Edden RAE; McAlonan GM; Arichi T; De Vita E Neuroimage; 2021 Jun; 233():117930. PubMed ID: 33711485 [TBL] [Abstract][Full Text] [Related]
13. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy. Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389 [TBL] [Abstract][Full Text] [Related]
15. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Abbott C; Bustillo J Curr Opin Psychiatry; 2006 Mar; 19(2):135-9. PubMed ID: 16612192 [TBL] [Abstract][Full Text] [Related]
16. Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. Bustillo JR; Chen H; Jones T; Lemke N; Abbott C; Qualls C; Canive J; Gasparovic C JAMA Psychiatry; 2014 Mar; 71(3):265-72. PubMed ID: 24402128 [TBL] [Abstract][Full Text] [Related]
17. Excitatory and inhibitory responses in the brain to experimental pain: A systematic review of MR spectroscopy studies. Archibald J; MacMillan EL; Enzler A; Jutzeler CR; Schweinhardt P; Kramer JLK Neuroimage; 2020 Jul; 215():116794. PubMed ID: 32278899 [TBL] [Abstract][Full Text] [Related]
18. Effects of repeated dizocilpine treatment on glutamatergic activity in the prefrontal cortex in an animal model of schizophrenia: An in vivo proton magnetic resonance spectroscopy study at 9.4T. Yoo CH; Song KH; Lim SI; Lee DW; Woo DC; Choe BY Neurosci Lett; 2017 Jan; 637():57-63. PubMed ID: 27894920 [TBL] [Abstract][Full Text] [Related]
19. Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies. Marsman A; van den Heuvel MP; Klomp DW; Kahn RS; Luijten PR; Hulshoff Pol HE Schizophr Bull; 2013 Jan; 39(1):120-9. PubMed ID: 21746807 [TBL] [Abstract][Full Text] [Related]
20. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study. Chiu PW; Lui SSY; Hung KSY; Chan RCK; Chan Q; Sham PC; Cheung EFC; Mak HKF Schizophr Res; 2018 Mar; 193():295-303. PubMed ID: 28751130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]